Cognition Therapeutics CGTX Earnings Call Transcripts

NASDAQ CGTX
$0.67 -0.02 (-2.95%)
At close: Nov 10, 2026 · 4:00 PM EST
1 earnings call on file for Cognition Therapeutics, Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Cognition Therapeutics Q3 2026 Earnings Call

Nov 5, 2026 3,225 words · 14 min read
  • Lisa RicciardiPresident and Chief Executive Officer
  • John DoyleChief Financial Officer
  • Tony CaggianoChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Cognition Therapeutics Earnings Call Transcripts

Calls1
LatestNov 5, 2026
SinceQ3 2026

Fiscal 2026

All 1 Cognition Therapeutics transcript Register to get access to Cognition Therapeutics’s earnings call transcripts.